Compare McDonald's Corp (MCD) vs Oscar Health Inc (OSCR) Price & Performance

McDonald's stock trades at $267.64, down slightly by 0.03% on the day, and is currently in a bearish technical trend according to moving averages. The company reported Q1 2026 earnings that beat expectations with EPS of $2.83 versus $2.74 expected, and revenue growth remains steady, reaching $26.89 billion in 2025. Recent news highlights the launch of the 'McDonald's NEXT' growth strategy focusing on automation and improved customer experience to counter competitive pressures.

The outlook for McDonald's is supported by strong fundamentals including a high net income margin of 31.62% and a consensus analyst price target of $329, implying significant upside. However, risks include inflationary pressures on franchisee margins and high long-term debt of $38.42 billion. Investor sentiment is mixed with a bearish technical signal but optimistic analyst ratings, with 58% recommending buy.

Oscar Health (OSCR) trades at $29.60, up 1.72% today, showing mixed signals with a bullish technical trend but bearish oscillators. The company reported revenue growth to $11.70B in 2025, though net income remains negative at -$443.15M. Recent earnings beat expectations in Q1 2026 with EPS of $2.07, while analyst sentiment is divided with a consensus price target of $24.67. Positive cash flow trends and media coverage highlight growth potential amid ongoing profitability challenges.

Outlook: OSCR offers growth exposure in health insurance with strong revenue expansion and cash flow, but profitability risks persist. Investment opportunity lies in execution toward breakeven, while risks include margin pressure and competitive threats. The stock's current price above consensus target suggests cautious optimism is warranted.